Arsenic trioxide as a novel anticancer agent against human transitional carcinoma--characterizing its apoptotic pathway. [electronic resource]
Producer: 20020919Description: 293-300 p. digitalISSN:- 0959-4973
- Antineoplastic Agents -- therapeutic use
- Apoptosis -- drug effects
- Arsenic Trioxide
- Arsenicals -- therapeutic use
- Buthionine Sulfoximine -- therapeutic use
- Carcinoma, Transitional Cell -- drug therapy
- Caspase 3
- Caspases -- metabolism
- Cisplatin -- pharmacology
- DNA, Neoplasm -- drug effects
- Drug Resistance, Neoplasm
- Enzyme Activation
- G1 Phase -- drug effects
- Humans
- Membrane Potentials -- drug effects
- Mitochondria -- metabolism
- Oxides -- therapeutic use
- Reactive Oxygen Species -- metabolism
- Signal Transduction
- Tumor Cells, Cultured -- drug effects
- Urinary Bladder Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.